Abstract
The work of the Research Program is concentrated on new immunological methods of tumor diagnostics as well as on immunological concepts for tumor therapy and the investigation of the biological mechanisms underlying processes of cellular interaction and metastatic spreading.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected publications
Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.H., Peter, M.E.: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated Proteins Form a Death-inducing Signalling Complex (DISC) with the Receptor. EMBO J. 14, 5579–5588 (1995)
Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., Wallach, D.: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803–815 (1996)
Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’ Rourke, K., Shevchenko, A., Scaffidi, C., Zhang, M., Ni, J., Gentz, R., Mann, M., Krammer, PH., Peter, M.E., Dixit, V.M.: FLICE, a Novel FADD-homologous ICE/CED-3-like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex (DISC). Cell 85, 817–827 (1996)
Eck, H.-P., Stahl-Hennig, C., Hunsmann, G., Dröge, W.: Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet 338, 346–347 (1991)
Dröge, W., Eck, H.-P., Mihm, S.: HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetyl-cysteine. Immunol. Today 13, 211–214 (1992)
GroĂŸ, A., Hack, V., Stahl-Hennig, C., Dröge, W.: Elevated hepatic γ-glutamylcysteine syn¬thetase activity and abnormal sulfate levels in liver and muscle tissue may explain abnor¬mal cysteine and glutathione levels in SlV-in- fected rhesus macaques. AIDS Res. and Human Retroviruses 12, 1639–1641 (1996)
Hack, V., GroĂŸ, A., Kinscherf, R., Bockstette, M., Fiers, W., Berke, G., Dröge, W.: Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia. FASEB J. 10, 1219–1226 (1996)
Kinscherf, R., Hack, V., Fischbach, T., Friedmann, B., Weiss, C., Edler, L., Bartsch, P., Droge, W.: Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine. J. Mol. Med. 74, 393–400 (1996)
Hack, V., Schmid, D., Breitkreutz, R., Stahl- Hennig, C., Drings, P., Kinscherf, R., Taut, F., Holm, E., Dröge, W.: Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB J. 11, 84–92 (1997)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Peter, M.E., Krammer, P.H., Dröge, W. (1998). Tumor Immunology. In: Current Cancer Research 1998. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-95995-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-95995-0_10
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1122-4
Online ISBN: 978-3-642-95995-0
eBook Packages: Springer Book Archive